EndoGastric Solutions, Inc. Unveils New Research Demonstrating the Benefits of Transoral Incisionless Fundoplication (TIF®) vs. Maximum PPI Therapy
5/14/2013 11:09:42 AM
More...
|
Healthcare Industry Veterans Join EndoGastric Solutions, Inc. Management Team
1/14/2013 7:16:54 AM
More...
|
EndoGastric Solutions, Inc. Completes Patient Enrollment in Clinical Trial Comparing TIF Procedure to PPI Therapy for the Treatment of GERD
10/2/2012 10:11:13 AM
More...
|
10,000th Patient in the United States Treated With Transoral Incisionless Fundoplication (TIF®) Using EsophyX® Technology From EndoGastric Solutions, Inc.
9/6/2012 9:57:35 AM
More...
|
EndoGastric Solutions, Inc. Announces Second Randomized Controlled Trial Comparing TIF Procedure to PPI Therapy for the Treatment of GERD
6/28/2012 9:56:05 AM
More...
|
First Patient Enrolled and Treated in the U.S. for EndoGastric Solutions, Inc.’s Randomized Study of Transoral Incisionless Fundoplication (TIF(R))
6/23/2011 11:10:06 AM
More...
|
EndoGastric Solutions, Inc. Announces Significant Expansion of U.S. Data Supporting Transoral Fundoplication
2/18/2011 7:59:17 AM
More...
|
EndoGastric Solutions, Inc. Achieves 5,000 NOS Cases Milestone
10/1/2010 8:41:03 AM
More...
|
EndoGastric Solutions, Inc. Completes $30 Million Financing Round
8/30/2010 6:38:19 AM
More...
|
EndoGastric Solutions, Inc. Announces Launch of U.S. TIF Registry
5/11/2010 10:14:06 AM
More...
|
|